Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $15,811 - $96,473
64 Added 2.23%
2,932 $758,000
Q2 2022

Jul 27, 2022

BUY
$237.11 - $299.66 $680,031 - $859,424
2,868 New
2,868 $728,000
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $534,607 - $656,149
-2,078 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $64,841 - $73,040
222 Added 11.96%
2,078 $684,000
Q3 2021

Oct 20, 2021

BUY
$272.21 - $332.43 $102,895 - $125,658
378 Added 25.58%
1,856 $565,000
Q2 2021

Aug 06, 2021

BUY
$225.08 - $271.69 $332,668 - $401,557
1,478 New
1,478 $397,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.